DiaMedica Therapeutics Insider Trades

DMAC

Track insider trading activity from DiaMedica Therapeutics executives and directors. See which insiders are buying and selling DMAC stock.

Trades Last 12 Months

DMAC Price

All Insider Trades for DiaMedica Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pauls Dietrich John President & CEO
Holding Value $1.2M 128,791 shares
Last Trade
Aug 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 60,200 shares
$6.65
$9.29
Holding Value $446k 47,963 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.2k 3,355 shares
$8.42
$9.29
Parsons James T. Director
Holding Value $910k 97,949 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85k 10,095 shares
$8.42
$9.29
Holding Value $3.7M 398,587 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52k 6,175 shares
$8.42
$9.29
Stahlberg Jan 10% owner
Holding Value $82M 8,825,742 shares
Last Trade
Nov 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$626k 73,099 shares
$8.57
$9.29
Krop Julie Chief Marketing Officer
Holding Value $4.18M 450,000 shares
Last Trade
Aug 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.06M 450,000 shares
$4.58
$9.29
Von Koch Thomas 10% owner
Holding Value $77.9M 8,383,577 shares
Last Trade
Jul 23, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.7M 2,857,142 shares
$5.15
$9.29
Jacinto Richard Ii 10% owner
Holding Value $46.1M 4,958,823 shares
Last Trade
Jul 23, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.06M 400,000 shares
$5.15
$9.29
Kuntz Richard Director
Holding Value $299k 32,162 shares
Last Trade
Jun 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 32,162 shares
$4.11
$9.29
Lewis Tanya Director
Holding Value $299k 32,162 shares
Last Trade
Jun 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 32,162 shares
$4.11
$9.29
Wambeke David J. Chief Business Officer
Holding Value $2.32M 250,000 shares
Last Trade
Jun 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.03M 250,000 shares
$4.11
$9.29
Kellen Scott CFO & Secretary
Holding Value $2.09M 225,000 shares
Last Trade
Jun 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$925k 225,000 shares
$4.11
$9.29
Holding Value $2.91M 312,995 shares
Last Trade
Apr 07, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$83.5k 24,000 shares
$3.48
$9.29
Cundari Dominic R Chief Commercial Officer
Holding Value $139k 15,000 shares
Last Trade
Jun 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.5k 15,000 shares
$2.90
$9.29
Daves Julie Vanorsdel SVP Clinical Development Oper.
Holding Value $502k 54,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 54,000 shares
$2.73
$9.29
Gruis Kirsten L Chief Medical Officer
Holding Value $622k 67,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$183k 67,000 shares
$2.73
$9.29
Burroughs Amy L. Director
Holding Value $681k 73,288 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.2k 17,156 shares
$1.53
$9.29
Tomenterprise Ab Director
Holding Value $26.5M 2,855,827 shares
Last Trade
Jul 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$277k 207,974 shares
$1.33
$9.29
Alcorn Harry W Jr Svp, Clinical Operations
Holding Value $405k 43,582 shares
Last Trade
Sep 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$57k 15,000 shares
$3.80
$9.29
Gilman Sydney A. Vp, Regulatory Affairs
Holding Value $232k 25,000 shares
Last Trade
Jul 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.8k 25,000 shares
$3.47
$9.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up